Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

OVID

Ovid Therapeutics Inc

May 13 • 04:00PM ET

2.80

-0.07 -2.44 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NGNE VYGR ANNX WVE CAPR

| Held by: VTI VXF SURI BSVO DFMC DFAS PRFZ QQQS AVSC DCOR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.24	Insider Own	11.24%	Shs Outstand	167.27M	Perf Week	0.72%
Market Cap	484.51M	Forward P/E	-	EPS next Y	-0.53	Insider Trans	-0.10%	Shs Float	153.59M	Perf Month	-5.41%
Enterprise Value	342.06M	PEG	-	EPS next Q	-0.11	Inst Own	40.56%	Short Float	5.55%	Perf Quarter	76.10%
Income	-24.17M	P/S	68.05	EPS this Y	-103.04%	Inst Trans	10.09%	Short Ratio	2.69	Perf Half Y	107.41%
Sales	7.12M	P/B	2.36	EPS next Y	-13.73%	ROA	-15.73%	Short Interest	8.53M	Perf YTD	71.78%
Book/sh	1.19	P/C	3.12	EPS next 5Y	-	ROE	-18.77%	52W High	3.11 -9.82%	Perf Year	879.02%
Cash/sh	0.90	P/FCF	-	EPS past 3/5Y	32.53% 29.81%	ROIC	-11.51%	52W Low	0.27 936.65%	Perf 3Y	-22.65%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	68.99% -10.48%	Gross Margin	97.26%	Volatility	6.42% 5.95%	Perf 5Y	-15.15%
Dividend TTM	-	EV/Sales	48.04	EPS Y/Y TTM	30.81%	Oper. Margin	-670.25%	ATR (14)	0.18	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.17	Sales Y/Y TTM	1199.64%	Profit Margin	-339.31%	RSI (14)	55.48	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.17	EPS Q/Q	13.39%	SMA20	0.79%	Beta	0.19	Target Price	5.25
Payout	-	Debt/Eq	0.07	Sales Q/Q	-100.00%	SMA50	12.07%	Rel Volume	0.58	Prev Close	2.87
Employees	23	LT Debt/Eq	0.06	Earnings	May 12 BMO	SMA200	66.88%	Avg Volume	3.17M	Price	2.80
IPO	May 05, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.83% -100.00%	Trades		Volume	1,829,403	Change	-2.44%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)